Aquestive Therapeutics | 4:持股变动声明-高管 Wargacki Stephen
Aquestive Therapeutics | 4:持股变动声明-董事 Jenkins Abigail L.
Aquestive Therapeutics | 8-K:重大事件
Aquestive Therapeutics | 10-Q:季度报表
Aquestive Therapeutics | 8-K:Aquestive Therapeutics公布2024年第一季度财务业绩并提供业务最新情况
Aquestive Therapeutics | 8-K:重大事件
Aquestive Therapeutics | ARS:年度报告
Aquestive Therapeutics | DEFA14A:其他
Aquestive Therapeutics | DEF 14A:股东委托书决议
Aquestive Therapeutics | 3:首次持股声明-董事 Jenkins Abigail L.
Aquestive Therapeutics | 424B2:募资说明书
Aquestive Therapeutics | 424B2:募资说明书
Aquestive Therapeutics | EFFECT:其他
Aquestive Therapeutics | 8-K:重大事件
Aquestive Therapeutics | CORRESP:信函
Aquestive Therapeutics | CORRESP:信函
Aquestive Therapeutics | CORRESP:信函
Aquestive Therapeutics | UPLOAD:其他
Aquestive Therapeutics | S-3:特定交易注册声明
Aquestive Therapeutics | SC 13G:超过5%持股股东披露文件-Venrock Healthcare Capital Partners III, L.P.(6.5%),VHCP Co-Investment Holdings III, LLC(6.5%)等
暂无数据